Similar articles

• Getting over testosterone: postulating a fresh start for etiologic studies of prostate cancer.

  Carpenter WR, Robinson WR, Godley PA. Carpenter WR, et al. J Natl Cancer Inst. 2008 Feb 6;100(3):158-9. doi: 10.1093/jnci/djm329. Epub 2008 Jan 29. J Natl Cancer Inst. 2008. PMID: 18230791 No abstract available.
• The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.

  Platz EA, Giovannucci E. Platz EA, et al. J Steroid Biochem Mol Biol. 2004 Nov;92(4):237-53. doi: 10.1016/j.jsbmb.2004.10.002. Epub 2005 Jan 5. J Steroid Biochem Mol Biol. 2004. PMID: 15663987 Review.
• Circulating steroid hormones and the risk of prostate cancer.

  Severi G, Morris HA, MacInnis RJ, English DR, Tilley W, Hopper JL, Boyle P, Giles GG. Severi G, et al. Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):86-91. doi: 10.1158/1055-9965.EPI-05-0633. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16434592
• Editorial comment. Sex hormones and the risk of incident prostate cancer.

  Thomas JA 2nd, Bañez L, Freedland SJ. Thomas JA 2nd, et al. Urology. 2010 Nov;76(5):1040-1. doi: 10.1016/j.urology.2010.02.040. Urology. 2010. PMID: 21056251 No abstract available.
• Sex steroid hormone metabolism and prostate cancer.

  Soronen P, Laiti M, Törn S, Härkönen P, Patrikainen L, Li Y, Pulkka A, Kurkela R, Herrala A, Kaija H, Isomaa V, Vihko P. Soronen P, et al. J Steroid Biochem Mol Biol. 2004 Nov;92(4):281-6. doi: 10.1016/j.jsbmb.2004.10.004. Epub 2004 Dec 19. J Steroid Biochem Mol Biol. 2004. PMID: 15663991 Review.